Small molecule identification for the restoration of p53 pathway through p73 and by degradation of mutant p53

被引：0
|
作者：
Borrero, Liz J. Hernandez
Zhao, Shengliang
Dicker, David T.
El-Deiry, Wafik
机构：
[1] Fox Chase Canc Ctr, Dept Med Oncol, Lab Translat Oncol & Expt Canc Therapeut, Philadelphia, PA 19111 USA
[2] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2643
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2643
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML
    Kim, EJ
    Park, JS
    Um, SJ
    NUCLEIC ACIDS RESEARCH, 2003, 31 (18) : 5356 - 5367
  • [32] Functional restoration of mutant p53 using targeted small molecule reactivators
    Khadiullina, R.
    Mirgayazova, R.
    Chasov, V.
    Clarke, J. Stevenson
    Rizvanov, A.
    Baud, M.
    Bulatov, E.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 : 130 - 130
  • [33] Targeting p53 by small molecule p53 activators in multiple myeloma
    Manujendra N Saha
    Yijun Yang
    Hong Chang
    Journal of Hematology & Oncology, 5 (Suppl 1)
  • [34] Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53
    Hong, Bo
    Prabhu, Varun V.
    Zhang, Shengliang
    van den Heuvel, A. Pieter J.
    Dicker, David T.
    Kopelovich, Levy
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2014, 74 (04) : 1153 - 1165
  • [35] Ubiquitination and degradation of mutant p53
    Lukashchuk, Natalia
    Vousden, Karen H.
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (23) : 8284 - 8295
  • [36] Small-molecule NSC58874 releases and activates p73 via induction of mutant p53 degradation in cancer cells.
    Zhang, Shengliang
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
    Y Li
    C Prives
    Oncogene, 2007, 26 : 2220 - 2225
  • [38] Targeting mutant p53 through the mevalonate pathway
    Freed-Pastor, William
    Prives, Carol
    NATURE CELL BIOLOGY, 2016, 18 (11) : 1122 - 1124
  • [39] MUTANT P53 GAIN OF ONCOGENIC FUNCTION IN HEPATOCELLULAR CARCINOMA IS DUE TO THEIR INHIBITORY INTERACTION WITH P53 FAMILY MEMBERS P63 AND P73
    Schleithoff, Elisa Schulze
    Kairat, Astrid
    Koch, Andreas F.
    Lorenz, Katja
    Sfremmel, Wolfgang
    Mueller, Martina
    HEPATOLOGY, 2008, 48 (04) : 987A - 988A
  • [40] Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
    Li, Y.
    Prives, C.
    ONCOGENE, 2007, 26 (15) : 2220 - 2225
12345